116 related articles for article (PubMed ID: 8101877)
1. New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study.
Liégeois JF; Bruhwyler J; Damas J; Nguyen TP; Chleide EM; Mercier MG; Rogister FA; Delarge JE
J Med Chem; 1993 Jul; 36(15):2107-14. PubMed ID: 8101877
[TBL] [Abstract][Full Text] [Related]
2. Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potential central nervous system agents: synthesis and neurochemical study.
Liégeois JF; Rogister FA; Bruhwyler J; Damas J; Nguyen TP; Inarejos MO; Chleide EM; Mercier MG; Delarge JE
J Med Chem; 1994 Feb; 37(4):519-25. PubMed ID: 7907148
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of CNS activities of [1,2,3]triazolo[4,5-b][1,5]-, imidazolo[4,5-b][1,5]-, and pyrido[2,3-b][1,5]benzodiazepines. 10-Piperazinyl-4H-1,2,3-triazolo[4,5-b][1,5]benzodiazepines with neuroleptic activity.
Chakrabarti JK; Hotten TM; Pullar IA; Steggles DJ
J Med Chem; 1989 Oct; 32(10):2375-81. PubMed ID: 2571731
[TBL] [Abstract][Full Text] [Related]
4. 4-Piperazinyl-10H-thieno[2,3-b][1,5]benzodiazepines as potential neuroleptics.
Chakrabarti JK; Horsman L; Hotten TM; Pullar IA; Tupper DE; Wright FC
J Med Chem; 1980 Aug; 23(8):878-84. PubMed ID: 6105216
[TBL] [Abstract][Full Text] [Related]
5. 10-Piperazinyl-4H-theino[3,2-b][1,5]- and -[3,4-b][1,5]benzodiazepines as potential neuroleptics.
Chakrabarti JK; Fairhurst J; Gutteridge NJ; Horsman L; Pullar IA; Smith CW; Steggles DJ; Tupper DE; Wright FC
J Med Chem; 1980 Aug; 23(8):884-9. PubMed ID: 6105217
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.
Liégeois JF; Bruhwyler J; Damas J; Rogister F; Masereel B; Geczy J; Delarge J
Eur J Pharmacol; 1995 Feb; 273(3):R1-3. PubMed ID: 7737323
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of typical neuroleptics, clozapine and newly synthesized clozapine-analogues: correlations between neurochemistry and behaviour.
Bruhwyler J; Liégeois JF; Chleide E; Rogister F; Damas J; Delarge J; Mercier M
Behav Pharmacol; 1992 Dec; 3(6):567-579. PubMed ID: 11224158
[TBL] [Abstract][Full Text] [Related]
8. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H
J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566
[TBL] [Abstract][Full Text] [Related]
9. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
Norman MH; Rigdon GC; Navas F; Cooper BR
J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and atypical antipsychotic profile of some 2-(2-piperidinoethyl)benzocycloalkanones as analogues of butyrophenone.
Fontenla JA; Osuna J; Rosa E; Castro ME; G-Ferreiro T; Loza-García I; Calleja JM; Sanz F; Rodríguez J; Raviña E
J Med Chem; 1994 Aug; 37(16):2564-73. PubMed ID: 7914540
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship studies of CNS agents. XII. 1-[4-(4-aryl-1-piperazinyl)butyl]-3,4-dihydro-2(1H)-quinolinones: new 5-HT1A, 5-HT2 and D2 ligands with a potential antipsychotic activity.
Mokrosz JL; Chojnacka-Wójcik E; Dereń-Wesołek A; Kłodzińska A; Maćkowiak M; Bielecka Z; Paluchowska MH
Drug Des Discov; 1994 Apr; 11(3):197-203. PubMed ID: 7548635
[TBL] [Abstract][Full Text] [Related]
12. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
13. Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indoles.
Perregaard J; Arnt J; Bøgesø KP; Hyttel J; Sánchez C
J Med Chem; 1992 Mar; 35(6):1092-101. PubMed ID: 1348090
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition.
van den Buuse M; Gogos A
J Pharmacol Exp Ther; 2007 Mar; 320(3):1224-36. PubMed ID: 17194799
[TBL] [Abstract][Full Text] [Related]
15. The importance of serotonin-dopamine interactions in the action of clozapine.
Meltzer HY
Br J Psychiatry Suppl; 1992 May; (17):22-9. PubMed ID: 1358125
[TBL] [Abstract][Full Text] [Related]
16. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs.
Meltzer HY; Matsubara S; Lee JC
Psychopharmacol Bull; 1989; 25(3):390-2. PubMed ID: 2576319
[TBL] [Abstract][Full Text] [Related]
17. Derivatives of 11-(1-piperazinyl)-5H-pyrrolo[2,1-c][1,4]benzodiazepine as central nervous system agents.
Wright WB; Greenblatt EN; Day IP; Quinones NQ; Hardy RA
J Med Chem; 1980 Apr; 23(4):462-5. PubMed ID: 6103960
[TBL] [Abstract][Full Text] [Related]
18. Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate).
Morimoto T; Hashimoto K; Yasumatsu H; Tanaka H; Fujimura M; Kuriyama M; Kimura K; Takehara S; Yamagami K
Neuropsychopharmacology; 2002 Apr; 26(4):456-67. PubMed ID: 11927170
[TBL] [Abstract][Full Text] [Related]
19. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent.
Moore NA; Tye NC; Axton MS; Risius FC
J Pharmacol Exp Ther; 1992 Aug; 262(2):545-51. PubMed ID: 1354253
[TBL] [Abstract][Full Text] [Related]
20. Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds.
Ishizumi K; Kojima A; Antoku F; Saji I; Yoshigi M
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2139-51. PubMed ID: 8582016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
